Haemonetics (HAE) Operating Expenses (2016 - 2025)
Historic Operating Expenses for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $135.0 million.
- Haemonetics' Operating Expenses rose 35.09% to $135.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $531.3 million, marking a year-over-year decrease of 363.79%. This contributed to the annual value of $527.1 million for FY2025, which is 9.04% up from last year.
- Latest data reveals that Haemonetics reported Operating Expenses of $135.0 million as of Q4 2025, which was up 35.09% from $136.3 million recorded in Q3 2025.
- Over the past 5 years, Haemonetics' Operating Expenses peaked at $146.0 million during Q1 2024, and registered a low of $98.0 million during Q4 2021.
- Its 5-year average for Operating Expenses is $122.5 million, with a median of $121.4 million in 2023.
- In the last 5 years, Haemonetics' Operating Expenses surged by 10874.54% in 2021 and then crashed by 1661.24% in 2025.
- Quarter analysis of 5 years shows Haemonetics' Operating Expenses stood at $98.0 million in 2021, then increased by 17.75% to $115.4 million in 2022, then increased by 14.26% to $131.9 million in 2023, then increased by 1.99% to $134.5 million in 2024, then increased by 0.35% to $135.0 million in 2025.
- Its last three reported values are $135.0 million in Q4 2025, $136.3 million for Q3 2025, and $138.4 million during Q2 2025.